• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

U.K. National Institute for Health & Care Excellence (NICE)

UK regulators recommend iRhythm cardiac arrythmia device

December 2, 2020 By Sean Whooley

iRhythm Technologies (NSDQ:IRTC) announced that it received a recommendation for adoption from National Institute for Health and Care Excellence (NICE). San Francisco-based iRhythm said in a news release that it is the first technology to pass through a new digital health tech pilot, resulting in the successful recommendation for adoption from NICE. The company’s Zio XT […]

Filed Under: Business/Financial News, Cardiovascular, Medicare, Patient Monitoring, Regulatory/Compliance Tagged With: Centers for Medicare and Medicaid Services (CMS), iRhythm Technologies Inc., U.K. National Institute for Health & Care Excellence (NICE)

UK recommends Axonics SNM for overactive bladder

September 8, 2020 By Sean Whooley

Axonics Modulation Technologies (NSDQ:AXNX) announced today that NICE suggested using its r-SNM system in the UK. The National Institute for Health and Care Excellence (NICE) offers evidence-based guidance to the UK and, in guidance published last week, it recommended Axonics’ sacral neuromodulation (SNM) system for treating refractory overactive bladder for the country’s National Health Service (NHS). […]

Filed Under: Clinical Trials, Neurological, Neuromodulation/Neurostimulation Tagged With: Axonics Modulation Technologies, U.K. National Health Service (NHS), U.K. National Institute for Health & Care Excellence (NICE)

U.K.’s NICE recommends Axonics’ device for overactive bladder treatment

February 18, 2020 By Sean Whooley

The U.K.’s National Institute for Health and Care Excellence (NICE) recommended the sacral neuromodulation (SNM) system developed by Axonics Modulation Technologies (NSDQ:AXNX) for treating overactive bladder in its latest draft guidance. Axonics’ system is the only SNM device approved for full-body MRI scans without needing the device explanted, according to the company. The device itself is […]

Filed Under: Business/Financial News, Neurological, Neuromodulation/Neurostimulation Tagged With: Axonics Modulation Technologies, U.K. National Institute for Health & Care Excellence (NICE)

British health agency backs endobronchial valves from Pulmonx, OIympus

December 21, 2017 By Brad Perriello

Pulmonx and Olympus (TYO:7733) won a nod from a British health agency for the endobronchial valves they sell to treat severe emphysema. The U.K.’s National Institute for Health & Care Excellence updated its guidance for the valves, saying it considers the clinical evidence behind them sufficient to support routine use. The one-way valves, Pulmonx’s Zephyr and the Spiration […]

Filed Under: Respiratory Tagged With: Olympus, Pulmonx, U.K. National Institute for Health & Care Excellence (NICE)

British health watchdog recommends vaginal mesh ban

November 27, 2017 By Brad Perriello

A British health watchdog reportedly plans to recommend that the National Health Service there ban vaginal mesh implants to treat pelvic organ prolapse, citing “serious but well-recognized safety concerns.” In recommending that the implants be limited to research use only, the U.K.’s National Institute for Health & Care Excellence said “evidence of long-term efficacy [for implants […]

Filed Under: Gynecological Tagged With: Pelvic Mesh Lawsuits, U.K. National Institute for Health & Care Excellence (NICE)

HeartFlow wins nod from U.K. healthcare board

February 13, 2017 By Brad Perriello

The U.K.’s National Institute for Health & Care Excellence issued final guidance on HeartFlow‘s FFRct technology, which uses algorithms to generate 3D models of blood flows and can help diagnose heart disease. The British agency recommended the use of FFRct for patients with stable, recent-onset chest pain, finding that the technology is safe, has a high level of diagnostic […]

Filed Under: Cardiovascular, Diagnostics, Imaging Tagged With: HeartFlow, Reimbursement, U.K. National Institute for Health & Care Excellence (NICE)

Realizing the value of med-tech innovations

November 5, 2014 By MassDevice Contributors Network Leave a Comment

300px-flag_of_the_united_kingdom.png

By Tim Kofol, S2N Health

Filed Under: News Well Tagged With: Bayer, Edwards Lifesciences, Innovation, S2N Health, The Business of Emerging Medtech , U.K. National Institute for Health & Care Excellence (NICE)

U.K. poised to ban metal-on-metal hips

October 30, 2013 By Brad Perriello Leave a Comment

The U.K. is poised to ban metal-on-metal hips

Regulators in the U.K. are reportedly poised to ban the use of metal-on-metal hip implants after finding unacceptably high rates of failure in a review of 17,000 cases.

The proposed ban, which would affect hospitals in the U.K.’s National Health Service, follows a review by the country’s National Institute for Health & Care Excellence that found failure rates as high as 43% for some of the implants, The Telegraph reported.

Filed Under: Implants, Metal-on-Metal, News Well, Regulatory/Compliance Tagged With: Hips, U.K. National Health Service (NHS), U.K. National Institute for Health & Care Excellence (NICE)

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy